Global Head and Neck Cancer Drugs/Therapeutics Market Size, Status and Forecast 2025

March 2018 | 95 pages | ID: G30796613C0EN
QYResearch

Abstracts

This report studies the global Head and Neck Cancer Drugs/Therapeutics market, analyzes and researches the Head and Neck Cancer Drugs/Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• Bristol-Myers Squibb
• Merck & Co.
• Eli Lilly
• Sanofi
• Merck Group

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, the product can be split into

• PD Inhibitors
• EGFR Inhibitors
• Microtubule Inhibitors

Market segment by Application, Head and Neck Cancer Drugs/Therapeutics can be split into

• Hospital
• Clinic
• Research Institute
• Laboratories

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Head and Neck Cancer Drugs/Therapeutics Market Size, Status and Forecast 2025

1 INDUSTRY OVERVIEW OF HEAD AND NECK CANCER DRUGS/THERAPEUTICS

1.1 Head and Neck Cancer Drugs/Therapeutics Market Overview
  1.1.1 Head and Neck Cancer Drugs/Therapeutics Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Head and Neck Cancer Drugs/Therapeutics Market Size and Analysis by Regions (2013-2018)
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Head and Neck Cancer Drugs/Therapeutics Market by Type
  1.3.1 PD Inhibitors
  1.3.2 EGFR Inhibitors
  1.3.3 Microtubule Inhibitors
1.4 Head and Neck Cancer Drugs/Therapeutics Market by End Users/Application
  1.4.1 Hospital
  1.4.2 Clinic
  1.4.3 Research Institute
  1.4.4 Laboratories

2 GLOBAL HEAD AND NECK CANCER DRUGS/THERAPEUTICS COMPETITION ANALYSIS BY PLAYERS

2.1 Head and Neck Cancer Drugs/Therapeutics Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Bristol-Myers Squibb
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Head and Neck Cancer Drugs/Therapeutics Revenue (Million USD) (2013-2018)
  3.1.5 Recent Developments
3.2 Merck & Co.
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Head and Neck Cancer Drugs/Therapeutics Revenue (Million USD) (2013-2018)
  3.2.5 Recent Developments
3.3 Eli Lilly
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Head and Neck Cancer Drugs/Therapeutics Revenue (Million USD) (2013-2018)
  3.3.5 Recent Developments
3.4 Sanofi
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Head and Neck Cancer Drugs/Therapeutics Revenue (Million USD) (2013-2018)
  3.4.5 Recent Developments
3.5 Merck Group
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Head and Neck Cancer Drugs/Therapeutics Revenue (Million USD) (2013-2018)
  3.5.5 Recent Developments

4 GLOBAL HEAD AND NECK CANCER DRUGS/THERAPEUTICS MARKET SIZE BY TYPE AND APPLICATION (2013-2018)

4.1 Global Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2013-2018)
4.2 Global Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2013-2018)
4.3 Potential Application of Head and Neck Cancer Drugs/Therapeutics in Future
4.4 Top Consumer/End Users of Head and Neck Cancer Drugs/Therapeutics

5 UNITED STATES HEAD AND NECK CANCER DRUGS/THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Head and Neck Cancer Drugs/Therapeutics Market Size (2013-2018)
5.2 United States Head and Neck Cancer Drugs/Therapeutics Market Size and Market Share by Players (2013-2018)
5.3 United States Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2013-2018)

6 EU HEAD AND NECK CANCER DRUGS/THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Head and Neck Cancer Drugs/Therapeutics Market Size (2013-2018)
6.2 EU Head and Neck Cancer Drugs/Therapeutics Market Size and Market Share by Players (2013-2018)
6.3 EU Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2013-2018)

7 JAPAN HEAD AND NECK CANCER DRUGS/THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Head and Neck Cancer Drugs/Therapeutics Market Size (2013-2018)
7.2 Japan Head and Neck Cancer Drugs/Therapeutics Market Size and Market Share by Players (2013-2018)
7.3 Japan Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2013-2018)

8 CHINA HEAD AND NECK CANCER DRUGS/THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

8.1 China Head and Neck Cancer Drugs/Therapeutics Market Size (2013-2018)
8.2 China Head and Neck Cancer Drugs/Therapeutics Market Size and Market Share by Players (2013-2018)
8.3 China Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2013-2018)

9 INDIA HEAD AND NECK CANCER DRUGS/THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

9.1 India Head and Neck Cancer Drugs/Therapeutics Market Size (2013-2018)
9.2 India Head and Neck Cancer Drugs/Therapeutics Market Size and Market Share by Players (2013-2018)
9.3 India Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2013-2018)

10 SOUTHEAST ASIA HEAD AND NECK CANCER DRUGS/THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Head and Neck Cancer Drugs/Therapeutics Market Size (2013-2018)
10.2 Southeast Asia Head and Neck Cancer Drugs/Therapeutics Market Size and Market Share by Players (2013-2018)
10.3 Southeast Asia Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2013-2018)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2018-2025)

11.1 Global Head and Neck Cancer Drugs/Therapeutics Market Size (Value) by Regions (2018-2025)
  11.1.1 United States Head and Neck Cancer Drugs/Therapeutics Revenue and Growth Rate (2018-2025)
  11.1.2 EU Head and Neck Cancer Drugs/Therapeutics Revenue and Growth Rate (2018-2025)
  11.1.3 Japan Head and Neck Cancer Drugs/Therapeutics Revenue and Growth Rate (2018-2025)
  11.1.4 China Head and Neck Cancer Drugs/Therapeutics Revenue and Growth Rate (2018-2025)
  11.1.5 India Head and Neck Cancer Drugs/Therapeutics Revenue and Growth Rate (2018-2025)
  11.1.6 Southeast Asia Head and Neck Cancer Drugs/Therapeutics Revenue and Growth Rate (2018-2025)
11.2 Global Head and Neck Cancer Drugs/Therapeutics Market Size (Value) by Type (2018-2025)
11.3 Global Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2018-2025)

12 HEAD AND NECK CANCER DRUGS/THERAPEUTICS MARKET DYNAMICS

12.1 Head and Neck Cancer Drugs/Therapeutics Market Opportunities
12.2 Head and Neck Cancer Drugs/Therapeutics Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Head and Neck Cancer Drugs/Therapeutics Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Head and Neck Cancer Drugs/Therapeutics Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Head and Neck Cancer Drugs/Therapeutics Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Head and Neck Cancer Drugs/Therapeutics Market Share by Regions (2013-2018)
Figure United States Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure EU Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Head and Neck Cancer Drugs/Therapeutics Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Head and Neck Cancer Drugs/Therapeutics Revenue Market Share by Type in 2017
Figure PD Inhibitors Market Size (Million USD) and Growth Rate (2013-2018)
Figure EGFR Inhibitors Market Size (Million USD) and Growth Rate (2013-2018)
Figure Microtubule Inhibitors Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Head and Neck Cancer Drugs/Therapeutics Market Share by Application in 2017
Figure Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) and Growth Rate in Hospital (2013-2018)
Figure Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) and Growth Rate in Clinic (2013-2018)
Figure Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) and Growth Rate in Research Institute (2013-2018)
Figure Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) and Growth Rate in Laboratories (2013-2018)
Table Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure Head and Neck Cancer Drugs/Therapeutics Market Size Share by Players in 2013
Figure Head and Neck Cancer Drugs/Therapeutics Market Size Share by Players in 2017
Table Bristol-Myers Squibb Basic Information List
Table Head and Neck Cancer Drugs/Therapeutics Business Revenue (Million USD) of Bristol-Myers Squibb (2013-2018)
Figure Bristol-Myers Squibb Head and Neck Cancer Drugs/Therapeutics Business Revenue Market Share (2013-2018)
Table Merck & Co. Basic Information List
Table Head and Neck Cancer Drugs/Therapeutics Business Revenue (Million USD) of Merck & Co. (2013-2018)
Figure Merck & Co. Head and Neck Cancer Drugs/Therapeutics Business Revenue Market Share (2013-2018)
Table Eli Lilly Basic Information List
Table Head and Neck Cancer Drugs/Therapeutics Business Revenue (Million USD) of Eli Lilly (2013-2018)
Figure Eli Lilly Head and Neck Cancer Drugs/Therapeutics Business Revenue Market Share (2013-2018)
Table Sanofi Basic Information List
Table Head and Neck Cancer Drugs/Therapeutics Business Revenue (Million USD) of Sanofi (2013-2018)
Figure Sanofi Head and Neck Cancer Drugs/Therapeutics Business Revenue Market Share (2013-2018)
Table Merck Group Basic Information List
Table Head and Neck Cancer Drugs/Therapeutics Business Revenue (Million USD) of Merck Group (2013-2018)
Figure Merck Group Head and Neck Cancer Drugs/Therapeutics Business Revenue Market Share (2013-2018)
Table Global Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) by Product (2013-2018)
Figure Global Head and Neck Cancer Drugs/Therapeutics Revenue Market Share (%) by Product (2013-2018)
Figure Global Head and Neck Cancer Drugs/Therapeutics Market Share by Product in 2017
Table Global Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2013-2018)
Figure Global Head and Neck Cancer Drugs/Therapeutics Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Head and Neck Cancer Drugs/Therapeutics
Figure United States Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure United States Head and Neck Cancer Drugs/Therapeutics Market Size Share by Players in 2013
Figure United States Head and Neck Cancer Drugs/Therapeutics Market Size Share by Players in 2017
Table United States Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2013-2018)
Figure United States Head and Neck Cancer Drugs/Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure United States Head and Neck Cancer Drugs/Therapeutics Market Size Share by Application in 2017
Figure EU Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table EU Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure EU Head and Neck Cancer Drugs/Therapeutics Market Size Share by Players in 2013
Figure EU Head and Neck Cancer Drugs/Therapeutics Market Size Share by Players in 2017
Table EU Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2013-2018)
Figure EU Head and Neck Cancer Drugs/Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure EU Head and Neck Cancer Drugs/Therapeutics Market Size Share by Application in 2017
Figure Japan Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure Japan Head and Neck Cancer Drugs/Therapeutics Market Size Share by Players in 2013
Figure Japan Head and Neck Cancer Drugs/Therapeutics Market Size Share by Players in 2017
Table Japan Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2013-2018)
Figure Japan Head and Neck Cancer Drugs/Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure Japan Head and Neck Cancer Drugs/Therapeutics Market Size Share by Application in 2017
Figure China Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table China Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure China Head and Neck Cancer Drugs/Therapeutics Market Size Share by Players in 2013
Figure China Head and Neck Cancer Drugs/Therapeutics Market Size Share by Players in 2017
Table China Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2013-2018)
Figure China Head and Neck Cancer Drugs/Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure China Head and Neck Cancer Drugs/Therapeutics Market Size Share by Application in 2017
Figure India Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table India Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure India Head and Neck Cancer Drugs/Therapeutics Market Size Share by Players in 2013
Figure India Head and Neck Cancer Drugs/Therapeutics Market Size Share by Players in 2017
Table India Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2013-2018)
Figure India Head and Neck Cancer Drugs/Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure India Head and Neck Cancer Drugs/Therapeutics Market Size Share by Application in 2017
Figure Southeast Asia Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Head and Neck Cancer Drugs/Therapeutics Market Size Share by Players in 2013
Figure Southeast Asia Head and Neck Cancer Drugs/Therapeutics Market Size Share by Players in 2017
Table Southeast Asia Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2013-2018)
Figure Southeast Asia Head and Neck Cancer Drugs/Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Head and Neck Cancer Drugs/Therapeutics Market Size Share by Application in 2017
Figure Global Head and Neck Cancer Drugs/Therapeutics Market Size and Growth Rate (2018-2025)
Table Global Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) by Regions (2018-2025)
Figure Global Head and Neck Cancer Drugs/Therapeutics Market Size Share (2018-2025)
Figure Global Head and Neck Cancer Drugs/Therapeutics Market Size Share by Regions in 2025
Figure United States Head and Neck Cancer Drugs/Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure EU Head and Neck Cancer Drugs/Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Head and Neck Cancer Drugs/Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Head and Neck Cancer Drugs/Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Head and Neck Cancer Drugs/Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Head and Neck Cancer Drugs/Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) by Type (2018-2025)
Figure Global Head and Neck Cancer Drugs/Therapeutics Market Size Share by Type in 2018
Figure Global Head and Neck Cancer Drugs/Therapeutics Market Size Share by Type in 2025
Table Global Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) by Application (2018-2025)
Figure Global Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) by Application in 2018
Figure Global Head and Neck Cancer Drugs/Therapeutics Market Size (Million USD) by Application in 2025